The first cosmetic-only neuromodulator, designed for relaxing the muscles that cause moderate to severe frown lines between the eyebrows, is Jeuveau™. Denver’s Dr. Joel Cohen at AboutSkin Dermatology and DermSurgery was a principal investigator in the clinical trial that led to the injectable’s FDA approval in 2019. In addition, Dr. Cohen authored a 400-page academic textbook on the subject of neuromodulators and their use, has published extensively about the subject, and lectures internationally on the topic.
Though Jeuveau™ is a newer cosmetic dermatology option for addressing wrinkles, the Board-Certified Dermatologists at AboutSkin are experienced injectors who have worked for years with similar treatments, including BOTOX®, Dysport®, and Xeomin®. This collective experience allows patients to feel confident that they are working with aesthetic physicians that are the highest echelon of medical professionals—who understand the available treatments, facial anatomy and balance, and how to maximize both safety and aesthetic results.
As director of AboutSkin Dermatology, the nationally renowned Dr. Cohen oversees the practice.
READ MOREDr. Stoler has provided medical and surgical services at AboutSkin Dermatology since 2011.
READ MOREDr. Ho joined AboutSkin Dermatology in 2012, and provides medical and surgical services.
READ MOREDr. Fettig came to AboutSkin in 2019 after completing her Boston University residency.
READ MOREDr.Brooke E. Rothstein has joined AboutSkin Dermatology after graduating from Tufts University.
READ MORE